These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36396760)

  • 41. Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis.
    Costello E; Rock S; Stratakis N; Eckel SP; Walker DI; Valvi D; Cserbik D; Jenkins T; Xanthakos SA; Kohli R; Sisley S; Vasiliou V; La Merrill MA; Rosen H; Conti DV; McConnell R; Chatzi L
    Environ Health Perspect; 2022 Apr; 130(4):46001. PubMed ID: 35475652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population.
    Lind PM; Lind L; Salihovic S; Ahlström H; Michaelsson K; Kullberg J; Strand R
    Environ Res; 2022 Jun; 209():112677. PubMed ID: 35074350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study.
    Wen X; Wang M; Xu X; Li T
    Environ Health Perspect; 2022 Jun; 130(6):67007. PubMed ID: 35731224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
    Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
    Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between Per- and Polyfluoroalkyl Substances (PFAS) and Cardiometabolic Biomarkers in Adults of Czechia: The Kardiovize Study.
    Maranhao Neto GA; Polcrova AB; Pospisilova A; Blaha L; Klanova J; Bobak M; Gonzalez-Rivas JP
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations of exposure to perfluoroalkyl substances with serum uric acid change and hyperuricemia among Chinese women: Results from a longitudinal study.
    Feng Y; Fu M; Guan X; Wang C; Meng H; Zhou Y; He M; Guo H
    Chemosphere; 2022 Dec; 308(Pt 3):136438. PubMed ID: 36116625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drinking Water-Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study.
    Rosen EM; Kotlarz N; Knappe DRU; Lea CS; Collier DN; Richardson DB; Hoppin JA
    Environ Health Perspect; 2022 Sep; 130(9):97002. PubMed ID: 36069575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study.
    Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH
    Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations of single and multiple perfluoroalkyl substances exposure with folate among adolescents in NHANES 2007-2010.
    Tian Y; Luan M; Zhang J; Yang H; Wang Y; Chen H
    Chemosphere; 2022 Nov; 307(Pt 3):135995. PubMed ID: 35981617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: The Study of Women's Health Across the Nation.
    Ding N; Harlow SD; Batterman S; Mukherjee B; Park SK
    Environ Int; 2020 Feb; 135():105381. PubMed ID: 31841808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human serum poly- and perfluoroalkyl substance concentrations and their associations with gestational diabetes mellitus.
    Zhang Y; Chen R; Gao Y; Qu J; Wang Z; Zhao M; Bai X; Jin H
    Environ Pollut; 2023 Jan; 317():120833. PubMed ID: 36493933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study.
    Hu Y; Liu G; Rood J; Liang L; Bray GA; de Jonge L; Coull B; Furtado JD; Qi L; Grandjean P; Sun Q
    Environ Res; 2019 Dec; 179(Pt A):108775. PubMed ID: 31593837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2019 Aug; 129():343-353. PubMed ID: 31150976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demographic and exposure characteristics as predictors of serum per- and polyfluoroalkyl substances (PFASs) levels - A community-level biomonitoring project in Pennsylvania.
    Nair AS; Ma ZQ; Watkins SM; Wood SS
    Int J Hyg Environ Health; 2021 Jan; 231():113631. PubMed ID: 33035738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine.
    Jørgensen KT; Specht IO; Lenters V; Bach CC; Rylander L; Jönsson BA; Lindh CH; Giwercman A; Heederik D; Toft G; Bonde JP
    Environ Health; 2014 Dec; 13():116. PubMed ID: 25533644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.